🔎 Trials Near Me

Home › HIV › NCT07728123

Screen2Prevent (S2P)

RecruitingHealthy volunteers welcome

Screen2Prevent (S2P): Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department

Who can join

Ages 14 to 24 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Age 14-24 years, inclusive
* Present to the participating ED, regardless of chief complaint during the study period

Exclusion Criteria:

* None

About the study

Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).

What is being tested

Sponsor: Westat · Participants: 84,000 · Started: Jun 16, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07728123

Locations in the U.S.

FloridaUniversity of South Florida, Tampa
GeorgiaEmory Atlanta Adolescent Consortium, Atlanta
MarylandJohns Hopkins University, Baltimore
TennesseeSt. Jude Children's Research Hospital, Memphis
TexasBaylor College of Medicine, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.